Renal Cell Cancer Update
Management of Localized Non-Small Cell Lung Cancer with EGFR Tumor Mutations with Dr Roy Herbst
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:39:01
- Mais informações
Informações:
Sinopse
Dr Roy Herbst from the Yale Cancer Center discusses the clinical data on and optimal use of adjuvant osimertinib for patients with resected non-small cell lung cancer and an EGFR mutation. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayEGFRNSCLC21).
